Conclusion
Evaluation of diffuse liver disease is
the best validated application of USE
and has been widely adopted for non-invasive detection and staging of liver
fibrosis as well as monitoring liver treatment response. Focal breast lesion
USE has also been well studied and has been incorporated as an associated
feature in the 2nd edition of the BI-RADS US lexicon.
There is encouraging data that USE may
also be used to assess malignancy of focal liver lesions, thyroid nodules,
focal renal masses, and lymph nodes, grade renal fibrosis, and guide
TRUS-directed prostate biopsies, but further research with unbiased large scale
studies are still required. Also, technique standardization to allow comparison
of values between studies and development of new solutions for current
technical limitations and biologic/physiologic confounders need to be pursued.
USE holds immense potential for various clinical applications, and continued
development will lead to widespread clinical adoption in the upcoming years.
Không có nhận xét nào :
Đăng nhận xét